Multiportal Arthroscopy-assisted Surgical Resection of Diffuse-type Tenosynovial Giant Cell Tumors in the Ankle Joint Yields Favorable Clinical Outcomes: A Retrospective Study

被引:0
|
作者
Zhang, Jiayao [1 ,2 ,3 ]
Yao, Lei [1 ,2 ,3 ]
Sun, Yiyuan [1 ,4 ]
Li, Junqiao [1 ,2 ,3 ]
Hu, Yunan [1 ,2 ,3 ]
Chen, Kunhao [1 ,2 ,3 ]
Cai, Wufeng [1 ,2 ,3 ]
Zhang, Chenghao [1 ,2 ,3 ]
Li, Jian [1 ,2 ,3 ]
Li, Qi [1 ,2 ,3 ]
机构
[1] Sichuan Univ, West China Hosp, Sports Med Ctr, Chengdu 610041, Peoples R China
[2] Sichuan Univ, Dept Orthoped, Chengdu, Peoples R China
[3] Sichuan Univ, West China Hosp, Orthoped Res Inst, Chengdu, Peoples R China
[4] Sichuan Univ, West China Hosp, Day Surg Ctr, Chengdu, Peoples R China
关键词
Ankle; Arthroscopy; Diffuse-type tenosynovial giant cell tumor; Recurrence; Synovectomy; PIGMENTED VILLONODULAR SYNOVITIS; FOOT; RECURRENCE;
D O I
10.1111/os.14180
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Objective: Diffuse-type tenosynovial giant cell tumors (Dt-TGCTs) commonly occur in the knee joint and tend to recur postoperatively. However, limited clinical data are available on ankle joint involvement especially associated multiportal arthroscopic treatment outcomes. The purpose of this study was to report the clinical results of multiportal arthroscopy-assisted resection of Dt-TGCTs of the ankle. Methods: We retrospectively reviewed the clinical data of 33 patients with Dt-TGCT of the ankle who underwent multiportal arthroscopic treatment between August 2011 and December 2020. Clinical follow-up included the visual analogue scale (VAS) score, American Orthopedic Foot and Ankle Society (AOFAS) score, Kofoed score, and recurrence rate to assess surgical outcomes. The number of patients who achieved the patient acceptable symptom state (PASS) based on the AOFAS score was also examined. Additionally, the patients were categorized into two groups based on the final surgical approach: Group A who underwent multiportal arthroscopic synovectomy and Group AO who underwent combined arthroscopic and open surgical excision. Intergroup comparisons were conducted. Intraoperative characteristics, such as the number of patients with involvement of the tarsal tunnel and fibularis tendon and the Outerbridge grading of cartilage damage, were recorded to assess the selection of surgical procedures. Results: Among the 33 patients, 15 were assigned to Group A, and 18 were in Group AO. The median follow-up duration for the 33 patients was 77 months (range, 28-142 months). The median VAS score was 1 (range, 0-4), the AOFAS score was 96 (range, 65-100), and the Kofoed score was 96 (range, 67-100). A total of 27 patients (82%) achieved PASS based on AOFAS scores, while five patients (15%) had recurrence. No statistically significant difference was observed between the two groups in recurrence rate, follow-up VAS score, AOFAS score, Kofoed score, or number of patients who reached the PASS (p > 0.05). In the AO group, 16 cases of Dt-TGCT involved the tarsal tunnel, and 11 cases involved the fibularis tendon. All these patients exhibited extension beyond the joint. In contrast, only one patient in Group A had involvement of the tarsal tunnel. Statistically significant differences were observed between the groups (p < 0.001). Conclusion: This study demonstrated that, with the assistance of a multiportal arthroscopic approach, surgical excision of Dt-TGCT in the ankle resulted in favorable clinical outcomes with a relatively low recurrence rate. Additionally, patients with extra-articular involvement were more likely to require concomitant open surgery.
引用
收藏
页码:2680 / 2687
页数:8
相关论文
共 13 条
  • [1] Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study
    Mastboom, Monique J. L.
    Palmerini, Emanuela
    Verspoor, Floortje G. M.
    Rueten-Budde, Anja J.
    Stacchiotti, Silvia
    Staals, Eric L.
    Schaap, Gerard R.
    Jutte, Paul C.
    Aston, Will
    Gelderblom, Hans
    Leithner, Andreas
    Dammerer, Dietmar
    Takeuchi, Akihiko
    Thio, Quirina
    Niu, Xiaohui
    Wunder, Jay S.
    van de Sande, Michiel A. J.
    LANCET ONCOLOGY, 2019, 20 (06): : 877 - 886
  • [2] Active surveillance of diffuse-type tenosynovial giant cell tumors: A retrospective, multicenter cohort study
    Spierenburg, Geert
    Staals, Eric L.
    Palmerini, Emanuela
    Randall, Robert Lor
    Thorpe, Steven W.
    Wunder, Jay S.
    Ferguson, Peter C.
    Verspoor, Floortje G. M.
    Houdek, Matthew T.
    Bernthal, Nicholas M.
    Schreuder, Bart H. W. B.
    Gelderblom, Hans
    van de Sande, Michiel A. J.
    van der Heijden, Lizz
    EJSO, 2024, 50 (02):
  • [3] First prospective observational study in diffuse-type tenosynovial giant cell tumors.
    Mastboom, Monique
    Palmerini, Emanuela
    Stacchiotti, Silvia
    Staals, Eric
    Schreuder, Bart
    Bauer, Sebastian
    Healey, John H.
    Lopez Bastida, Julio
    Gelderblom, Hans
    Leithner, Andreas
    van de Sande, Michiel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] What Are the Recurrence Rates, Complications, and Functional Outcomes After Multiportal Arthroscopic Synovectomy for Patients With Knee Diffuse-type Tenosynovial Giant-cell Tumors?
    Yao, Lei
    Li, Yinghao
    Li, Tao
    Fu, Weili
    Chen, Gang
    Li, Qi
    Tang, Xin
    Li, Jian
    Xiong, Yan
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2024, 482 (07) : 1218 - 1229
  • [5] CORR Insights®: What Are the Recurrence Rates, Complications, and Functional Outcomes After Multiportal Arthroscopic Synovectomy for Patients With Knee Diffuse-type Tenosynovial Giant-cell Tumors?
    Bus, Michael
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2024, 482 (07) : 1230 - 1231
  • [6] Invasion Patterns and Long-Term Clinical Outcomes of Diffuse Tenosynovial Giant Cell Tumor of the Ankle Joint
    Yotsuya, Kumiko
    Shido, Yoji
    Matsuyama, Yukihiro
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [7] Clinical Outcomes of Arthroscopy-Assisted Modified Triple Endobutton Plate Fixation in Rockwood Type III Acute Acromioclavicular Joint Dislocation: A Retrospective Study
    Jiang, Hantao
    Tong, Jingling
    Shen, Liping
    Jin, Gang
    Zhu, Rangteng
    ORTHOPAEDIC SURGERY, 2022, 14 (10) : 2436 - 2446
  • [8] Randomized, placebo-controlled, double blind, phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors.
    Takeuchi, Akihiko
    Endo, Makoto
    Kawai, Akira
    Nishida, Yoshihiro
    Terauchi, Ryu
    Matsumine, Akihiko
    Aiba, Hisaki
    Nakamura, Tomoki
    Tandai, Susumu
    Ozaki, Toshifumi
    Hoshi, Manabu
    Yoshimura, Kenichi
    Nomura, Akihiro
    Murayama, Toshinori
    Tsuchiya, Hiroyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocol
    Takeuchi, Akihiko
    Nomura, Akihiro
    Yamamoto, Norio
    Hayashi, Katsuhiro
    Igarashi, Kentaro
    Tandai, Susumu
    Kawai, Akira
    Matsumine, Akihiko
    Miwa, Shinji
    Nishida, Yoshihiro
    Nakamura, Tomoki
    Terauchi, Ryu
    Hoshi, Manabu
    Kunisada, Toshiyuki
    Endo, Makoto
    Yoshimura, Kenichi
    Murayama, Toshinori
    Tsuchiya, Hiroyuki
    BMC MUSCULOSKELETAL DISORDERS, 2019, 20
  • [10] Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocol
    Akihiko Takeuchi
    Akihiro Nomura
    Norio Yamamoto
    Katsuhiro Hayashi
    Kentaro Igarashi
    Susumu Tandai
    Akira Kawai
    Akihiko Matsumine
    Shinji Miwa
    Yoshihiro Nishida
    Tomoki Nakamura
    Ryu Terauchi
    Manabu Hoshi
    Toshiyuki Kunisada
    Makoto Endo
    Kenichi Yoshimura
    Toshinori Murayama
    Hiroyuki Tsuchiya
    BMC Musculoskeletal Disorders, 20